We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-3.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$982M
AUM Growth
+$92.9M
Cap. Flow
+$134M
Cap. Flow %
13.65%
Top 10 Hldgs %
4.69%
Holding
1,940
New
653
Increased
414
Reduced
285
Closed
576

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$4.61M
2
DPZ icon
Domino's
DPZ
+$3.96M
3
BRKR icon
Bruker
BRKR
+$3.65M
4
TJX icon
TJX Companies
TJX
+$3.62M
5
SBUX icon
Starbucks
SBUX
+$3.58M

Sector Composition

Rank Sector Weight
1 Healthcare 17.3%
2 Industrials 16.2%
3 Technology 12.7%
4 Financials 11.7%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLBS icon
1326
Globus Maritime Ltd
GLBS
$68.8M
$101K 0.01%
34,620
-1,095
-3% -$3.33K
SIGA icon
1327
SIGA Technologies
SIGA
$219M
$101K 0.01%
+13,627
New +$87.3K
OBSV
1328
DELISTED
ObsEva SA Ordinary Shares
OBSV
$100K 0.01%
+32,036
New +$90.7K
HUGS.U
1329
DELISTED
USHG Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-third of one Warrant
HUGS.U
$100K 0.01%
+10,000
New +$99.9K
TTI icon
1330
TETRA Technologies
TTI
$1.26B
$93K 0.01%
+29,664
New +$95.2K
PTE
1331
DELISTED
PolarityTE, Inc. Common Stock
PTE
$92K 0.01%
+5,714
New +$111K
SYRE icon
1332
Spyre Therapeutics
SYRE
$9.25B
$89K 0.01%
+450
New +$78.7K
VTGN icon
1333
VistaGen Therapeutics
VTGN
$12.8M
$88K 0.01%
+1,066
New +$92.6K
TRUE
1334
DELISTED
TrueCar
TRUE
$87K 0.01%
+21,021
New +$97.6K
ITUB icon
1335
Itaú Unibanco
ITUB
$87.5B
$83K 0.01%
+21,569
New +$88.3K
EVLO
1336
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$82K 0.01%
+581
New +$115K
ADXS
1337
DELISTED
Advaxis Inc
ADXS
$80K 0.01%
+153,561
New +$71.3K
SCOR icon
1338
Comscore
SCOR
$109M
$74K 0.01%
+948
New +$75.1K
DM
1339
DELISTED
Desktop Metal, Inc.
DM
$74K 0.01%
+1,037
New +$90.1K
DS
1340
DELISTED
Drive Shack Inc.
DS
$70K 0.01%
24,966
-86,090
-78% -$232K
MUFG icon
1341
Mitsubishi UFJ Financial
MUFG
$254B
$68K 0.01%
+11,486
New +$63.8K
KALA icon
1342
KALA BIO
KALA
$14.5M
$66K 0.01%
+10
New +$86.3K
CRMD icon
1343
CorMedix
CRMD
$584M
$60K 0.01%
12,843
-654
-5% -$3.81K
VTNR
1344
DELISTED
Vertex Energy, Inc
VTNR
$56K 0.01%
+10,717
New +$85.1K
UPH
1345
DELISTED
UpHealth, Inc.
UPH
$56K 0.01%
+1,762
New +$92.1K
PAYS icon
1346
Paysign
PAYS
$705M
$52K 0.01%
19,239
+9,080
+89% +$24.3K
RAIL icon
1347
FreightCar America
RAIL
$260M
$49K 0.01%
+10,888
New +$57.4K
TONX
1348
TON Strategy Co
TONX
$169M
$49K 0.01%
+3
New +$50.9K
RGLS
1349
DELISTED
Regulus Therapeutics
RGLS
$45K ﹤0.01%
6,471
-14,156
-69% -$104K
EVFM
1350
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$45K ﹤0.01%
4,025
-16,759
-81% -$211K

Similar funds

GSA Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, GSA Capital Partners held 1,940 positions worth $982M, up 10% from $889M the previous quarter. Its ten largest holdings account for 4.7% of the portfolio.

GSA Capital Partners deployed $134M of net new capital in Q3 2021, opening 653 new positions and adding to 414 existing holdings. Its largest new stake was Openlane: 280,405 shares worth $4.6M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Amazon, an estimated $4.61M trimmed.

  • GSA Capital Partners's largest Q3 2021 buy was Openlane: 280,405 shares worth $4.6M.
  • GSA Capital Partners added most to BridgeBio Pharma in Q3 2021, an estimated $4.54M increase.
  • GSA Capital Partners's biggest Q3 2021 reduction was Amazon, cutting an estimated $4.61M.
  • GSA Capital Partners fully exited TJX Companies in Q3 2021, selling an estimated $3.62M.
  • GSA Capital Partners's ten largest holdings make up 4.7% of its $982M portfolio in Q3 2021.
  • GSA Capital Partners opened 653 new positions and closed 576 in Q3 2021.
  • GSA Capital Partners's portfolio value rose 10% quarter-over-quarter to $982M.

Based on GSA Capital Partners's 13F filing for Q3 2021, filed 12 Nov 2021.